This startup develops wearable neuro-prosthetics that screen for and correct impairments in the vestibular balance system. Their devices use sensors, non-invasive neuro-stimulation, and machine learning to provide personalized care for patients with balance disruptions, enabling doctors and physical therapists to deliver targeted interventions.
Funding
Funding not disclosed

Founders
Product
Problem
As people age, the vestibular system declines, leading to balance impairments that degrade quality of life, increase fall-related injuries, and reduce the ability to live independently. Current therapeutic options to restore disrupted balance are limited to experimental and high-risk vestibular implants.
Solution
Neursantys develops the NEURVESTA bioelectronics platform that enables discovery and delivery of non-invasive treatments for neuromotor conditions, initially targeting age-related balance decline. The NEURVESTA device delivers very low-level electrical stimulation of the vestibular system (EVS) through a wearable form factor. The device quantifies impairments to key components of the balance system and assesses individual patient responses to a range of stimulation parameters in real time as the EVS is applied. This allows for the development of proprietary EVS waveforms that deliver neuroplastic restoration of disrupted balance.
Target Audience
The primary users are neuromotor control researchers, clinical neurologists, senior living providers, rehabilitation providers, physical therapists, and space medicine researchers.
Features
- Wearable device delivering non-invasive electrical stimulation of the vestibular system (EVS)
- Proprietary bioelectronic treatment discovery technology to quantify balance system impairments
- Real-time assessment of patient responses to stimulation parameters
- EVS waveforms designed for neuroplastic restoration of balance
- Three 20-minute sessions per week for 6 weeks to deliver restoration of balance
- Treatments can be administered by medical staff with minimal training, and eventually by patients themselves at home